Article
Vitamin B2 and B3 nutrigenomics reveals a therapy for NAXD disease
25 Feb 2026
Abstract excerpt
Vitamins are essential metabolites that must be obtained from external sources. In modern times, they have become widely available, leading to their ad hoc consumption. We developed a nutritional genomics framework to systematically identify monogenic diseases responsive to micronutrient modulation. Genome-wide CRISPR screens under varying vitamin B2 and B3 levels revealed dozens of candidate disease genes...
Topics
Join the communities discussing this publication.
